EnWave Signs Technology License and Joint Development Agreement with GEA Lyophil GmbH to Advance REV(TM) Technology for Pharmaceutical Applications

Stock Information for EnWave Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About EnWave Corporation

EnWave Signs Technology Evaluation and License Option Agreement with Food Company Led by Michelin Star Chef
EnWave Declares Significant Sales Wins for Royalty-Partner BranchOut Food
EnWave Signs Royalty-Bearing Commercial License with Established South American Food Manufacturer
EnWave Reports 2024 First Quarter Consolidated Interim Financial Results
EnWave to Report First Quarter Financial Results on February 22, 2024 and Host Investor Conference Call
EnWave Signs Toll Manufacturing Agreement with BranchOut Food Inc. to Leverage REVworx Manufacturing Capacity
EnWave Signs Technology Evaluation and License Option Agreement with North American Multi-State Cannabis Company
EnWave Reports 2023 Fourth Quarter and Annual 2023 Consolidated Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.